申请人:Sansho Co., Ltd.
公开号:US05246949A1
公开(公告)日:1993-09-21
(A) a diacylated dopamine derivative represented by the formula (I): ##STR1## wherein R.sup.1 represents an alkyl group having 3 to 7 carbon atoms, a cycloalkyl group having 3 to 6 carbon atoms, substituted or unsubstituted phenyl group or a substituted or unsubstituted nitrogen-containing heterocyclic group; and R.sup.2 represents a hydrogen atom or a lower alkyl group; or a salt thereof; and (B) one or more compounds selected from lactic acid esters, fatty acid monoglycerides and higher alcohols; optionally together with (C) an unsaturated fatty acid monohydric alcohol ester. This preparation has a sustained effect, a high skin permeability and a low skin irritativeness.
(A)一种由公式(I)表示的二酰基多巴胺衍生物:##STR1## 其中,R1代表具有3至7个碳原子的烷基基团,具有3至6个碳原子的环烷基基团,取代或未取代的苯基团或取代或未取代的含氮杂环基团;R2代表氢原子或较低的烷基基团;或其盐;以及(B)选自乳酸酯,脂肪酸单甘酯和较高醇的一种或多种化合物;可选地与(C)不饱和脂肪酸单羟基醇酯一起。该制剂具有持久的效果,高皮肤渗透性和低皮肤刺激性。